Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial

Abstract BACKGROUND The Systolic Blood Pressure Intervention Trial (SPRINT) showed that targeting a systolic blood pressure (SBP) of ≤ 120 mm Hg (intensive treatment) reduced cardiovascular disease (CVD) events compared to SBP of ≤ 140 mm Hg (standard treatment); however, it is unclear if this effec...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hypertension 2018-01, Vol.31 (1), p.97-107
Hauptverfasser:	Still, Carolyn H, Rodriguez, Carlos J, Wright, Jackson T, Craven, Timothy E, Bress, Adam P, Chertow, Glenn M, Whelton, Paul K, Whittle, Jeffrey C, Freedman, Barry I, Johnson, Karen C, Foy, Capri G, He, Jiang, Kostis, John B, Lash, James P, Pedley, Carolyn F, Pisoni, Roberto, Powell, James R, Wall, Barry M
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome - epidemiology Acute Coronary Syndrome - etiology Aged Aged, 80 and over Antihypertensive Agents - adverse effects Antihypertensive Agents - therapeutic use Black or African American Black People Blood Pressure - drug effects Editor's Choice Ethnicity Female Heart Failure - epidemiology Heart Failure - etiology Hispanic or Latino Humans Hypertension - complications Hypertension - drug therapy Hypertension - epidemiology Male Middle Aged Myocardial Infarction - epidemiology Myocardial Infarction - etiology Original Contributions Racial Groups Socioeconomic Factors Stroke - epidemiology Stroke - etiology Systole Treatment Outcome White People
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!